Strides receives USFDA approval for Butalbital, Acetaminophen, and Caffeine Tablets

Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Butalbital, Acetaminophen, and Caffeine Tablets USP, 50 mg/325 mg/40 mg from the United States Food & Drug Administration (USFDA).

source https://www.pharmatutor.org/pharma-news/2020/strides-receives-usfda-approval-for-butalbital-acetaminophen-and-caffeine-tablets